Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts
暂无分享,去创建一个
[1] K. Weinberg,et al. Immunological reconstitution following bone marrow transplantation , 1997, Immunological reviews.
[2] R. Hirschtick,et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. , 1995, The New England journal of medicine.
[3] R. Storb,et al. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. , 1995, Bone marrow transplantation.
[4] Makiko Kobayashi,et al. CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV , 1995, Journal of leukocyte biology.
[5] R. Storb,et al. Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells. , 1995, Bone marrow transplantation.
[6] M. Mozes,et al. Cytotoxic T-cell role in renal allograft rejection and regulation. Renal allograft infiltrating cytotoxic T-cell line with suppressor-inducer function. , 1995, Human immunology.
[7] S. Steinberg,et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.
[8] D. Herndon,et al. Glycyrrhizin (20β-carboxy-11-oxo-30-norolean-12-en-3β-yl-2-O-β-d-glucopyranuronosyl-α-d-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1 , 1995 .
[9] J. Hermans,et al. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation. , 1994, Blood.
[10] J. Braun,et al. Abundance of a restricted fetal B cell repertoire in marrow transplant recipients. , 1994, Bone marrow transplantation.
[11] T. Ishikawa,et al. The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] T. Waldmann,et al. Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. , 1994, Blood.
[13] L. Hammarström,et al. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow. , 1994, Bone marrow transplantation.
[14] H. Deeg,et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. , 1994, Blood.
[15] R. Lechler,et al. Anergic T cells as suppressor cells in vitro. , 1994, Science.
[16] A. Barrett,et al. Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years , 1993, Annals of Internal Medicine.
[17] L. Lanier,et al. CD28- T lymphocytes. Antigenic and functional properties. , 1993, Journal of immunology.
[18] L. Picker,et al. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. , 1993, Journal of immunology.
[19] J. Giorgi,et al. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? , 1993, Bone marrow transplantation.
[20] A. Nagler,et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. , 1993, Bone marrow transplantation.
[21] P. Linsley,et al. The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.
[22] C. Cordonnier,et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. , 1992, The Journal of infectious diseases.
[23] K. Sullivan,et al. Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. , 1992, Transplantation.
[24] G. Sale,et al. Abnormal CD4:CD8 ratios and delayed germinal center reconstitution in lymph nodes of human graft recipients with graft-versus-host disease (GVHD): an immunohistological study. , 1992, Experimental hematology.
[25] J. Storek,et al. Reconstitution of B cell immunity following bone marrow transplantation. , 1992, Bone marrow transplantation.
[26] K. Sullivan,et al. Late complications of allogeneic and autologous marrow transplantation. , 1992, Bone marrow transplantation.
[27] S. Forman,et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation , 1991 .
[28] E. Thomas,et al. Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. , 1991, American journal of clinical pathology.
[29] G. Heller,et al. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. , 1990, Blood.
[30] M. Pepe,et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. , 1990, The Journal of infectious diseases.
[31] D. Musher,et al. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. , 1990, The Journal of infectious diseases.
[32] B. Blazar,et al. Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease. , 1990, Blood.
[33] J. Sheridan,et al. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation. , 1990, Blood.
[34] J. Phair,et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. , 1990, The New England journal of medicine.
[35] L. Lum. Recapitulation of immune ontogeny: a vital component for the success of bone marrow transplantation. , 1990, Cancer treatment and research.
[36] J. Hansen,et al. A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire. , 1989, Journal of immunology.
[37] R. Champlin,et al. B-cell dysfunction following human bone marrow transplantation: functional-phenotypic dissociation in the early posttransplant period. , 1989, Blood.
[38] G. Heller,et al. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts , 1989 .
[39] T. Tötterman,et al. Regeneration of functional and activated NK and T sub-subset cells in the marrow and blood after autologous bone marrow transplantation: a prospective phenotypic study with 2/3-color FACS analysis. , 1989, Leukemia.
[40] E. Minar,et al. Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease. , 1988, Annals of internal medicine.
[41] H. Deeg,et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. , 1988, Blood.
[42] M. Martelli,et al. Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation. , 1988, Blood.
[43] J. Klein,et al. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen , 1987 .
[44] H. Müller-Hermelink,et al. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. , 1987, The American journal of pathology.
[45] C. Cordonnier,et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. , 1987, Blood.
[46] R. Storb,et al. Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. , 1987, Blood.
[47] H. Deeg,et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.
[48] H. Deeg,et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.
[49] H. Deeg,et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. , 1985, Transplantation.
[50] H. Deeg,et al. RECOVERY OF IN VIVO CELLULAR IMMUNITY AFTER HUMAN MARROW GRAFTING: Influence of Time Postgrafting and Acute Graft‐Versus‐Host Disease , 1984, Transplantation.
[51] H. Wagner,et al. Functional asplenia in patients with chronic graft-versus-host disease: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] L. Petz,et al. Clinical bone marrow transplantation , 1983 .
[53] K. Sullivan,et al. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.
[54] R. Storb,et al. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets , 1982 .
[55] W. Friedrich,et al. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T-cell subpopulations having unique regulatory and cognitive functions. , 1982, Blood.
[56] W. Friedrich,et al. Abnormal humoral immune responses in peripheral blood lymphocyte cultures of bone marrow transplant recipients. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Storb,et al. In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease. , 1981, Blood.
[58] K. Sullivan,et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment , 1981 .
[59] R. Storb,et al. Total-body irradiation in preparation for marrow engraftment. , 1976, Transplantation proceedings.